Is Mitochondrial Oxidative Stress a Viable Therapeutic Target in Preeclampsia?
Despite considerable research efforts over the past few decades, the pathology of preeclampsia (PE) remains poorly understood with no new FDA-approved treatments. There is a substantial amount of work being conducted by investigators around the world to identify targets to develop therapies for PE....
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI AG
2022-01-01
|
| Edice: | Antioxidants |
| Témata: | |
| On-line přístup: | https://www.mdpi.com/2076-3921/11/2/210 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|